0001209191-23-036051.txt : 20230609
0001209191-23-036051.hdr.sgml : 20230609
20230609191051
ACCESSION NUMBER: 0001209191-23-036051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conterno Enrique A
CENTRAL INDEX KEY: 0001476151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 231006773
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-07
0
0000921299
FIBROGEN INC
FGEN
0001476151
Conterno Enrique A
C/O FIBROGEN, INC.
409 ILLINOIS STREET
SAN FRANCISCO
CA
94158
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-06-07
4
S
0
2791
17.0368
D
382708
D
Common Stock
2023-06-07
4
S
0
6106
17.0379
D
376602
D
Common Stock
27800
I
By Trust
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
2023-06-09